EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

CBioProfiler: A Web and Standalone Pipeline for Cancer Biomarker and Subtype Characterization

Xiaoping Liu iD, Zisong Wang iD, Hongjie Shi iD, Sheng Li iD, Xinghuan Wang iD

Genomics, Proteomics & Bioinformatics · 2024

DOI: 10.1093/gpbjnl/qzae045 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Genomics, Proteomics & Bioinformatics, 2024. Verfasst von Xiaoping Liu und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, Zhongnan Hospital of Wuhan University, Wuhan 430071, China. Hauptthemen laut MEDLINE: Biomarkers, Tumor, Neoplasms, Software, Internet. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cancer is a leading cause of death worldwide, and the identification of biomarkers and subtypes that can predict the long-term survival of cancer patients is essential for their risk stratification, treatment, and prognosis. However, there are currently no standardized tools for exploring cancer biomarkers or subtypes. In this study, we introduced Cancer Biomarker and subtype Profiler (CBioProfiler), a web server and standalone application that includes two pipelines for analyzing cancer biomarkers and subtypes. The cancer biomarker pipeline consists of five modules for identifying and annotating cancer survival-related biomarkers using multiple survival-related machine learning algorithms. The cancer subtype pipeline includes three modules for data preprocessing, subtype identification using multiple unsupervised machine learning methods, and subtype evaluation and validation. CBioProfiler also includes CuratedCancerPrognosisData, a novel R package that integrates reviewed and curated gene expression and clinical data from 268 studies. These studies cover 43 common blood and solid tumors and draw upon 47,686 clinical samples. The web server is available at https://www.cbioprofiler.com/ and https://cbioprofiler.znhospital.cn/CBioProfiler/, and the standalone app and source code can be found at https://github.com/liuxiaoping2020/CBioProfiler.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Biomarkers, TumorNeoplasmsSoftwareInternetHumansComputational Biology

Stichwörter der Autor:innen

CBioProfilerCancer biomarkerCancer subtypeMachine learningWeb app

Substanzen

Biomarkers, Tumor

Autor:innen und Institutionen

  • Department of Urology, Zhongnan Hospital of Wuhan University, Wuhan 430071, China.
  • Department of Pathology, Zhongnan Hospital of Wuhan University, Wuhan 430071, China.
  • Cancer Precision Diagnosis and Treatment and Translational Medicine Hubei Engineering Research Center, Zhongnan Hospital of Wuhan University, Wuhan 430071, China.
  • Department of Biological Repositories, Zhongnan Hospital of Wuhan University, Wuhan 430071, China.

ORCID-Profile: Xiaoping Liu, Zisong Wang, Hongjie Shi, Sheng Li, Xinghuan Wang

Zitieren

APA

Liu, X., Wang, Z., Shi, H., Li, S., & Wang, X. (2024). CBioProfiler: A Web and Standalone Pipeline for Cancer Biomarker and Subtype Characterization. Genomics, Proteomics & Bioinformatics. https://doi.org/10.1093/gpbjnl/qzae045

Vancouver

Liu X, Wang Z, Shi H, Li S, Wang X. CBioProfiler: A Web and Standalone Pipeline for Cancer Biomarker and Subtype Characterization. Genomics, Proteomics & Bioinformatics. 2024. doi:10.1093/gpbjnl/qzae045

BibTeX
@article{Liu2024,
  author = {Liu, Xiaoping and Wang, Zisong and Shi, Hongjie and Li, Sheng and Wang, Xinghuan},
  title = {CBioProfiler: A Web and Standalone Pipeline for Cancer Biomarker and Subtype Characterization},
  journal = {Genomics, Proteomics & Bioinformatics},
  year = {2024},
  doi = {10.1093/gpbjnl/qzae045}
}
Kostenlos starten →